 |
|
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(4):869-890. Published online 2023 Mar 14 DOI: https://doi.org/10.3350/cmh.2022.0420
|
|
Citations to this article as recorded by
 Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation
Ying‐Nan Tsai, Jia‐Ling Wu, Yao‐Chun Hsu
Alimentary Pharmacology & Therapeutics.2024; 59(1): 136. CrossRef Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 276. CrossRef Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
Chen-Te Huang, Tai-Chung Tseng
Clinical and Molecular Hepatology.2024; 30(2): 154. CrossRef Finite therapy of chronic hepatitis B infection: Cons
Yao-Chun Hsu
Clinical Liver Disease.2024;[Epub] CrossRef Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population‐based cohort study
Yao‐Chun Hsu, Yi‐Hsian Lin, Teng‐Yu Lee, Mindie H. Nguyen, Cheng‐Hao Tseng, Hsiu J. Ho, Feng‐Yu Kao, Jaw‐Town Lin, Chen‐Yi Wu, Chun‐Ying Wu
Alimentary Pharmacology & Therapeutics.2023; 58(4): 463. CrossRef Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real‐world study. Authors' reply
Yao‐Chun Hsu, Chun‐Ying Wu
Alimentary Pharmacology & Therapeutics.2023; 58(5): 550. CrossRef Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection—Authors' reply
Yao‐Chun Hsu, Mindie H. Nguyen, Chun‐Ying Wu
Alimentary Pharmacology & Therapeutics.2023; 58(7): 733. CrossRef
|